Source: Guideline 2012
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Philip H. Quanjer, Sanja Stanojevic, Tim J. Cole, Xaver Baur, Graham L. Hall, Bruce H. Culver, Paul L. Enright, John L. Hankinson, Mary S.M. Ip, Jinping Zheng, Janet Stocks and the ERS Global Lung Function Initiative. ERS TASK FORCE REPORT. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Guideline 2012

Member's Comments

No comment yet.

Related content which might interest you: Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations Source: Eur Respir J 2012; 40: 1324-1343 Year: 2012 LATE-BREAKING ABSTRACT: All-age multi-ethnic reference values for spirometry: The global lung function initiative (GLI) Source: Annual Congress 2012 - Predicting the future: the impact of reference values on a range of respiratory paramaters Year: 2012 "REDUCED MITOCHONDRIAL DENSITY IN THE VASTUS LATERALIS MUSCLE OF PATIENTS WITH COPD". H.R. GOSKER, M.K.C. HESSELINK, H. DUIMEL, K.A. WARD AND A.M.W.J. SCHOLS. EUR RESPIR J 2007; 30: 73 79. Source: Eur Respir J 2007; 30: 817 Year: 2007 RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD. EUR RESPIR J 2005; 26: 406-413. Source: Eur Respir J 2006; 27: 440 Year: 2006 LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Lung attacks in the ED: measurements to predict outcome. The AWARD study. Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 The global Lund function initiative (GLI) reference values do not reflect lung function in the Nordic countries Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 FOR PREPARATION: ERS abstract submission guidelines Source: Year: 2015 EOSINOPHIL COUNT AND FeNO AS PREDICTORS OF EXACERBACTIONS IN COPD Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 BODE INDEX IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 IMPACT OF SMOKE-FREE WORKPLACE LEGISLATION ON EXPOSURES AND HEALTH: POSSIBILITIES FOR PREVENTION. M.S. JAAKKOLA AND J.J.K. JAAKKOLA. EUR RESPIR J 2006; 28: 397-408. Source: Eur Respir J 2006 Oct 01;28(4):887-888 Year: 2006 Canadian prediction equation of spirometric lung function for caucasian adults 18-90 years: Results from the Canadian obstructive lung disease (COLD) study and the Canadian ECRHS study Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 "TACROLIMUS FOR ANTISYNTHETASE SYNDROME WITH INTERSTITIAL LUNG DISEASE?" [REPLY LETTER]. L.P. NICOD. EUR RESPIR J 2008; 32: 245-246. Source: Eur Respir J 2008; 32: 822 Year: 2008 Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 "LUNG VOLUME MEASUREMENTS" [REPLY LETTER]. M. CAZZOLA, V. BRUSASCO AND F.J. MARTINEZ. EUR RESPIR J 2008; 32: 528. Source: Eur Respir J 2008; 32: 822 Year: 2008 TORVAN VERSUS GAP: WHICH PERFORMS BETTER? Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Classification of PFT data using global lung initiative (GLI) and national health and nutrition examination survey (NHANES-III) models when extrapolated beyond the NHANES-III limit of 80 years of age Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013 The recent multi-ethnic global lung initiative 2012 (GLI2012) reference values don’t reflect contemporary Mediterranean spirometry Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION? EUR RESPIR J 2005; 26: 819-828. Source: Eur Respir J 2005; 26: 1191 Year: 2005 CAPTAIN: Effects of lung function at screening (FEV1 % predicted) as a continuous variable on treatment outcomes Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021